XXXX treatment effects on cognitive function: a meta-analysis.

@entity1 @entity227 @entity438 @entity439 @entity1756
UNASSIGNED: OBJECT The treatment of an unruptured @entity438 (UIA) is not free of morbidity and mortality, and the decision is made by weighing the risks of treatment complications against the risk of @entity1756 . This meta-analysis quantitatively analyzed the literature on the effects of UIA treatment on cognition. METHODS MEDLINE, Embase, and PsycInfo were systematically searched for studies that reported on the cognitive status of UIA @entity1 before and after @entity439 treatment. The search was restricted to prospective cohort and case-control studies published between January 1, 1998, and January 1, 2013. The analyses focused on the effect of treatment on general cognitive functioning, with an emphasis on 4 specific cognitive domains: executive functions, @entity227 . RESULTS Eight studies, with a total of 281 @entity1 , were included in the meta-analysis. Treatment did not affect general cognitive functioning (effect size [ES] -0.22 [95% CI -0.78 to 0.34]). Executive functions and verbal memory domains trended toward posttreatment impairment (ES -0.46 [95% CI -0.93 to 0.01] and ES -0.31 [95% CI -1.24 to 0.61]), and performance of visual memory tasks trended toward posttreatment improvement (ES 1.48 [95% CI -0.36 to 3.31]). Lastly, treatment did not significantly affect visuospatial functions (ES -0.08 [95% CI -0.30 to 0.45]). CONCLUSIONS The treatment of an UIA does not seem to affect long-term cognitive function. However, definitive conclusions were not possible due to the paucity of studies addressing this issue.
